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(CDEIS) providing validity for its use in clinical practice.
0849: PREDICTING THE DECISION MAKING ABILITY OF COLORECTAL
CANCER MULTI-DISCIPLINARY TEAMS: RESULTS OF AN OBSERVATIONAL
STUDY
Sujay Shah*,1, Sonal Arora 1, Pawan Mathur 2, Rob Glynne-Jones 3,
Nick Sevdalis 1. 1Imperial College, London, UK; 2Barnet Hospital, London, UK;
3Mount Vernon Cancer Centre, London, UK.
Introduction: To evaluate whether results from a validated tool can be
used to predict a MDTs ability to come to a clinical decision.
Methods: A prospective observational study assessed decision-making in
colorectal MDTs. Descriptive statistics and logistic regressions were
calculated.
Results: 423 patients were discussed at 24 colorectal cancer MDTs at a
single hospital. A clinical decision was reached in 347/ 423 cases (82%).
Reasons for no decision included insufﬁcient radiological information,
inadequate pathological information, lack of patient information, unavai-
lable clinical notes, and non- attendance of team members. Of the 347
cases where a decision was reached, this decision was implemented in 317
cases (91.4%). Reasons for non-implementation included change in pa-
tient's clinical condition (including requiring emergency admission), pa-
tient co-morbidity, patient choice and availability of additional clinical
information. The overall contribution percentage score was a signiﬁcant
positive predictor of whether or not decisions were made as well as
whether or not decisions were implemented.
Conclusions: Our results show that an MDT's ability to make and imple-
ment decisions is inﬂuenced by both information and team member
contributions. Speciﬁcally, the overall contribution percentage score is a
signiﬁcant positive predictor, and can be used to guide further MDT
training and structuring.
0868: TIME AS A PREDICTIVE DOMAIN FOR OUTCOME OF EMERGENCY
APPENDICECTOMY
S.J. Chapman*, N. Smith, J. Barnard, A.R. Hakeem, K.R. Prasad. St. James's
University Hospital, Leeds, UK.
Introduction: We sought to investigate time as a predictive domain for
outcomes of urgent appendicectomy for acute appendicitis (AA).
Methods: Retrospective chart review of a prospectively maintained
database. All patients undergoing emergency appendicectomy for AA be-
tween 1st Jan 2010-31st Dec 2012 were analysed. Primary outcomes:
histopathologically-proven AA and 30-day adverse events (composite
outcome: post-operative complications, return to theatre and return to
hospital). Time & day of admission, procedure and discharge were
extracted: (Day¼08:00-16:59; Evening¼17:00-22:59; Night¼23:00-
07:59) and (Weekday¼Mon 08:00-Fri 22:59; Weekend¼Fri 23:00-Mon
07:59) Kruskal-Wallis and Chi-squared analyses were performed
(alpha¼0.05).
Results: 953 patients were identiﬁed (Male¼54%; median age¼29). Lap-
aroscopy was the initial approach in 90.7% (n¼864). Adverse events
occurred in 18% (n¼172) [post-operative complications: n¼79; return to
theatre: n¼33; return to hospital: n¼92]. Greater incidence of adverse
events were associated with weekend admissions (p¼0.027) but not with
time (p¼0.066) or day (p¼0.486) of procedure. Histopathologically-proven
non-AA appendicectomy occurred in 24.0% (n¼229) [normal appendix
n¼100; other pathology n¼129). Increased incidence of normal histology
was associated with procedures performed at night (p¼0.01), but not with
time (p¼0.362) or day (p¼0.341) of admission.
Conclusions: The data highlights areas for targeted improvement in ser-
vice delivery and gains in clinical efﬁciency for management of AA.
0900: PUBLICS' AWARENESS OF DISORDERS AFFECTING THE BOWEL
AND RESEARCH ON BOWEL DISEASES e A POPULATION SURVEY
Simon Wong*,1, Anthony Ramsanahie 1, Deborah Gilbert 2,
Mohamed A. Thaha 1. 1Academic Surgical Unit, Blizard Institute, National
Centre for Bowel Research & Surgical Innovations, Barts & The London SMD,
Queen Mary University London, & The Royal London Hospital, UK; 2Bowel &
Cancer Research Charity, National Centre for Bowel Research & Surgical
Innovations, London, UK.
Introduction: The burden of bowel disorders is rapidly increasing
worldwide. Early recognition and intervention improve outcomes. Publics'awareness of 3-major bowel disorders (CRC, IBD, constipation)
was explored in this survey. Subjects answered questions on perception of
their bowel health, exercise, dietary behaviour and issues regarding
research.
Methods: A representative population sample was surveyed using a postal
delivered 26-point questionnaire with 3 sub-sections; “about you”, “bowel
health and you” and “bowel & cancer research” (binary responses).
Results: 66.3% (n¼214) were in the age group 46-78-years with only 2.3%
<30-group. 81.3% believed their bowel health is good, with 58.8% reporting
daily ﬁbre intake. Half of the sample had direct experience of bowel dis-
ease (family member/friend). 79% were aware of bowel symptoms relating
to bowel cancer but nearly half of the sample underestimated the burden
of bowel cancer. This ﬁgure was better for IBD (53.7% vs. 78.5%; CRC vs.
IBD). 81% were unaware of the poor funding resources available for
research on bowel conditions.
Conclusions: Publics' awareness of disease, its symptoms, and treatment
options alters their attitudes to the disease and help seeking behaviour.
Strategies focused on younger generation are required to improve their
engagement including research to beat bowel disorders.
1015: SAFETY AND EFFICACY OF PERMACOL® IN THE TREATMENT OF
FAECAL INCONTINENCE
Yahya Al-Abed, Abraham Ayantunde, Jennifer Ayers*,
Bandipalyam Praveen. Southend University Hospital, Westcliff on Sea, UK.
Introduction: Permacol is gaining popularity as an anal bulking agent for
the treatment of passive faecal incontinence FI. The aims are: (i) Evaluate
the safety and efﬁcacy of Permacol in the treatment of FI (ii) Assess patient
satisfaction.
Methods: A retrospective analysis of consecutive patients who had Per-
macol anal bulking injections over a 3-year period. Patients were evaluated
clinically and with anorectal physiological tests in a dedicated pelvic ﬂoor
clinic. Pre-and post-injection Cleveland Clinic Florida Incontinence Scores
(CCFIS) were calculated. A telephonic interview was carried out to assess
quality of life and patient outcome measures.
Results: 23 patients were included. 61% had complete response and 30%
partial response at a median of 8 weeks post injections. At 6-12 weeks post
injection, CCFIS showed signiﬁcant improvement from a mean of 13.5 (6-
20) at baseline to 5.1 (0-20) p<0.001. 21% required repeat injections with
further beneﬁts. We reported no adverse reaction to the injections and 88%
of the patients were satisﬁed with the outcomes.
Conclusions: Permacol injection for FI is safe, efﬁcacious and well toler-
ated by patients. The effect is not permanent, as some patients required
repeat injections. A large randomised controlled trial with long-term data
is desirable for this agent.
1036: ENDOSCOPIC STENTING OF OBSTRUCTING COLORECTAL CANCERS:
A SUITABLE THERAPEUTIC OPTION? A REVIEW OF EIGHT YEARS’ OF
DATA FROM A TERTIARY REFERRAL CENTRE
Robert Padwick*, Glenn Latham, James Francombe, Martin Osborne. South
Warwickshire Hospitals NHS foundation Trust, Warwick, UK.
Introduction: To establish whether stenting of obstructing colorectal
cancers (CRCs) is a suitable alternative to emergency resection in a local
setting.
Methods: All patients who underwent stenting of a CRC fromApril 2004 to
March 2012 were studied. Data were collected regarding reason for
stenting, time to stenting, success, complications, further surgery, and ﬁnal
outcomes.
Results: Sixty emergency and 5 planned stents were performed, patient
age range 25-98 (median 72). Twenty-ﬁve were performed as a bridge to
surgery, 27 due to advanced disease, 12 due to patient co-morbidity, and 7
due to patient choice. Time from referral to stent for emergency referrals
was 1-360 hours (median 23). Sixty-one stents were successfully
deployed. Perforation occurred in 2 patients and migration in 5 patients.
Twenty-one patients underwent planned surgery (time to surgery 2-208
days, median 24), 8 patients underwent emergency surgery (time to sur-
gery 0-79 days, median 5). 33 patients have died since stent insertion (time
to death 7-1263 days, median 203).
Conclusions: Stenting of obstructing colonic cancers is a viable alternative
to emergency resection, with a low complication rate. Stenting may allow a
proportion of patients to later undergo planned surgery. Stenting carries a
lower peri-procedure mortality than emergency resection.
